Lastly the authors are careful to say that this is only 1 year of data and 5 years of simulation, recognizing the value of a medication can slowly unfold after approval
If you are taking other diabetes medications, oral semaglutide may increase your risk of low blood sugar (hypoglycemia)
1 If the GLP-1 medication prescribed for diabetes management is held for longer than the dosing schedule, refer patients to their healthcare team for continued management to prevent the risk of hyperglycemia
New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Body Fat Without Loss of Muscle Mass The natural GLP-1 activator is clinically shown to support fat loss, including visceral fat reduction, while preserving lean muscle AUCKLAND, New Zealand, July 23, 2026 --(BUSINESS WIRE)--Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, announces today the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurb's effectiveness in weight loss and muscle preservation
Trends Mol
